Skip to main content
Glama

Sgd

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations (readOnly, openWorld, idempotent, non-destructive), the description discloses rich behavioral detail: graceful degradation of LEI/FIGI enrichment, ambiguity handling via figi_candidates, explicit unresolved fields, source labeling for identifiers, and the ISIN-to-LEI mapping behavior. This greatly helps an agent anticipate edge cases.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but extremely dense and front-loaded with example usage. Every sentence provides operational value—mapping input types to outputs, explaining ambiguity behavior, describing graceful degradation, and giving concrete examples. The structure is appropriate for the tool's complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

The description is comprehensive for a tool with only two parameters and no output schema. It covers when to use it, what inputs are accepted, what each supported type returns, how ambiguous cases are handled, how failures are reported, and how the tool behaves under external service outages. An agent has enough context to call and interpret the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3, but the description adds substantial value beyond the schema: it clarifies that the value must be the entity name only, warns against including trailing security-class words, explains the difference between company and drug values, and details what each type resolves to. This meaningfully compensates for anything the schema leaves implicit.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's function: resolving a user-spoken name to canonical/official identifiers needed by other tools. It gives concrete example queries ('What's the ticker for…'), names the resource (entity names to identifiers), and distinguishes itself from potential peers by emphasizing it is the first step when an ID is needed.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides explicit guidance: 'Use FIRST whenever you have a name but need an ID.' It also explains supported entity types and the acceptable input forms (ticker, CIK, ISIN, company name, brand/generic drug name). It does not explicitly name sibling alternatives or state when not to use the tool, so it stops short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Sgd toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Several tools have heavily overlapping purposes: ask_pipeworx, ask_pipeworx_beta (explicitly identical today), ask_pipeworx_grounded, deep_research, and validate_claim all route factual questions through similar pipelines. The polymarket_* cluster also blurs together, with arbitrage, edges, fill_risk, kalshi_spread, and bet_research all analyzing prediction-market mispricings from different angles.

Naming Consistency3/5

All names use consistent snake_case, but the verb/noun pattern is mixed: some are verb-first (compare_entities, generate_llms_txt, validate_claim), others noun-first (polymarket_edges, entity_profile, ai_visibility_check), and some are bare product names (ask_pipeworx, pipeworx_trending). Readable overall, but no single predictable convention.

Tool Count2/5

34 tools is far too many for a coherent server, especially since the server is named 'Sgd' but only 3 tools relate to yeast genetics. The remaining 31 tools span data lookup, prediction markets, memory, subscriptions, npm scanning, and llms.txt generation—an unfocused grab bag that should be split into multiple servers.

Completeness2/5

As an SGD yeast-genome server, the surface is thin: search, get_gene, and get_gene_go cover basic lookup but miss sequences, interactions, strains, homologs, and other standard SGD data. As a general data utility, the collection is broad but incoherent, with several one-off tools (generate_llms_txt, scan_dependency) that have no connection to the rest.

Resources